The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras(G12D); Pdx1-Cre (KC) mice

por Leal, Ana S., Misek, Sean A., Lisabeth, Erika M., Neubig, Richard R., Liby, Karen T.
Publicado 2019

Development of a 5-HT(7) receptor antibody for the rat: the good, the bad, and the ugly

por Thompson, Janice M., Tragge, Will, Flood, Emma D., Schulz, Stefan, Lisabeth, Erika, Watts, Stephanie W.
Publicado 2023

Development of a Cell-Based AlphaLISA Assay for High-Throughput Screening for Small Molecule Proteasome Modulators

por Staerz, Sophia D., Lisabeth, Erika M., Njomen, Evert, Dexheimer, Thomas S., Neubig, Richard R., Tepe, Jetze J.
Publicado 2023

Attenuation of Eph Receptor Kinase Activation in Cancer Cells by Coexpressed Ephrin Ligands

por Falivelli, Giulia, Lisabeth, Erika Mathes, de la Torre, Elena Rubio, Perez-Tenorio, Gizeh, Tosato, Giovanna, Salvucci, Ombretta, Pasquale, Elena B.
Publicado 2013

Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks

por Evelyn, Chris R., Lisabeth, Erika M., Wade, Susan M., Haak, Andrew J., Johnson, Craig N., Lawlor, Elizabeth R., Neubig, Richard R.
Publicado 2016

Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis

por Yu-Wai-Man, Cynthia, Spencer-Dene, Bradley, Lee, Richard M. H., Hutchings, Kim, Lisabeth, Erika M., Treisman, Richard, Bailly, Maryse, Larsen, Scott D., Neubig, Richard R., Khaw, Peng T.
Publicado 2017